PAM
CC icon

Palisade Asset Management’s Chemours CC Stock Holding History

Palisade Asset Management’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-13
Closed -$206 – 271
2025
Q3 		$206 Buy
+13
New +$189 ﹤0.01% 644
2024
Q2 		– Sell
-13
Closed -$342 – 229
2024
Q1 		$342 Buy
+13
New +$370 ﹤0.01% 400

Other funds holding CC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $4.21B AUM 44.81% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Palisade Asset Management's CC Position: Q4 2025 in Review

Palisade Asset Management sold out of Chemours (CC) in Q4 2025, closing a stake of 13 shares — an estimated $206 sold.

Palisade Asset Management first reported a position in CC in Q1 2024 and held it in 2 quarters. The position peaked at $342 in Q1 2024. 435 funds tracked by Wall St. Rank hold CC as of Q4 2025.

  • Palisade Asset Management reported no remaining Chemours position as of Q4 2025 after selling out during the quarter.
  • Palisade Asset Management sold 13 Chemours shares in Q4 2025, an estimated $206.
  • Palisade Asset Management first reported a position in Chemours in Q1 2024 and held it in 2 quarters.
  • Palisade Asset Management's Chemours position peaked at $342 in Q1 2024.
  • 435 funds tracked by Wall St. Rank held Chemours as of Q4 2025.

Based on Palisade Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.